Increasing Antiviral Usage in a UK Children's Hospital: A Call for Antiviral Stewardship

Orlagh McGarrity1, Sarah Prentice2,3, Duncan Shepherd4

  • 1From the Department of Pharmacy.

Insights

Antiviral use and costs significantly increased in hospitalized children, mainly due to anti-cytomegalovirus drugs. Pediatric stewardship programs should monitor antiviral prescribing, especially for high-risk children.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Pharmacy
  • Health Informatics

Background:

  • Limited data exist on antiviral consumption trends in pediatric hospital settings.
  • Understanding changes in antiviral prescribing is crucial for effective antimicrobial stewardship.
  • The period 2019-2024 encompasses significant global health events influencing healthcare utilization.

Purpose of the Study:

  • To analyze trends in antiviral medication usage and associated costs in hospitalized children.
  • To identify key drug classes driving changes in antiviral consumption.
  • To inform pediatric antimicrobial stewardship programs regarding antiviral prescribing practices.

Main Methods:

  • Retrospective analysis of electronic prescribing records from a large UK children's hospital.
  • Data collection spanned from 2019 to 2024.
  • Quantification of antiviral prescriptions and associated costs, with a focus on specific drug categories.

Main Results:

  • A significant increase in overall antiviral usage and expenditure was observed between 2019 and 2024.
  • Anti-cytomegalovirus medications were the primary drivers of this increased consumption.
  • Specific trends in antiviral prescribing patterns were identified within the pediatric inpatient population.

Conclusions:

  • Pediatric antimicrobial stewardship initiatives need to incorporate antiviral stewardship components.
  • Enhanced monitoring of antiviral use is recommended, particularly in centers managing children vulnerable to severe viral infections.
  • The findings highlight the need for updated guidelines on antiviral prescribing in pediatric care.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...